1. Home
  2. Resources
  3. Pediatric COVID-19 Vaccines

Pediatric COVID-19 Vaccines

About Pediatric COVID-19 Vaccines

The Centers for Disease Control and Prevention (CDC) recommends everyone ages 6 months and older get vaccinated against COVID-19 as well as a booster for everyone 5 years and older, if eligible. See the CDC’s recommended COVID-19 Vaccination Schedules here

Although fewer children have been infected with COVID-19 compared to adults, children can:

  • Be infected with the virus that causes COVID-19
  • Get sick from COVID-19
  • Spread COVID-19 to others

Get a COVID-19 vaccine for your child as soon as you can.

  • COVID-19 vaccines are safe and effective.
  • COVID-19 vaccines have been used under the most intensive safety monitoring in U.S. history.
  • Your child will not get the COVID-19 virus from any COVID-19 vaccine, including the Pfizer-BioNTech (Comirnaty) COVID-19 vaccine or Moderna (Spikevax( COVID-19 vaccine.
  • Your child may get a COVID-19 vaccine and other vaccines at the same visit or without waiting 14 days between vaccines.

Cases of myocarditis and pericarditis in adolescents and young adults have been reported more often after getting the second dose than after the first dose of one of the two mRNA COVID-19 vaccines, Pfizer-BioNTech or Moderna. These reports are rare and the known and potential benefits of COVID-19 vaccination outweigh the known and potential risks, including the possible risk of myocarditis or pericarditis.

Children who get infected with COVID-19 can also develop serious complications like multisystem inflammatory syndrome (MIS-C)—a condition where different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. Since the pandemic began, more than 2,300 cases of MIS-C have been reported in children ages 5 through 11 years. Children with underlying medical conditions are more at risk for severe illness from COVID-19 compared with children without underlying medical conditions.

To learn more about (MIS-C): MIS-C FAQ

See the CDC’s statement on COVID-19 Vaccines for Children and Teens for further info and clinical data.

Pfizer-BioNTech (Comirnaty) COVID-19 Vaccine

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have authorized the use of the Pfizer-BioNTech COVID-19 vaccine for children ages 6 months and up

  • Children 6 months through 4 years of age who have not yet begun their three-dose primary series of the Pfizer-BioNTech COVID-19 Vaccine or have not yet received the third dose of their primary series will now receive the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine as the third dose in their primary series following two doses of the monovalent Pfizer-BioNTech COVID-19 Vaccine with a 21-day interval between the first and second dose and an 8-week interval between the second and third doses.
  • At this time, children 6 months through 4 years of age who have already completed their three-dose primary series with the original (monovalent) Pfizer-BioNTech COVID-19 Vaccine will not be eligible for a booster dose of an updated bivalent vaccine.
  • Children aged 5 years and up should receive 2 doses with an interval of 3 to 8 weeks.
  • After completion of the primary series, children 5 years and up should receive the Updated Booster (bivalent) at least two months after receiving their last dose, regardless of type (primary series or booster).

For more information, please refer to the following resources:

Moderna (Spikevax) COVID-19 Vaccine

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have authorized the use of the Moderna COVID-19 vaccine for children ages 6 months and up.

  • Children 6 months through 5 years of age who received the monovalent Moderna COVID-19 Vaccine with an interval of 4 to 8 weeks are now eligible to receive a single booster of the updated (bivalent) Moderna COVID-19 Vaccine two months after completing a primary series with the monovalent Moderna COVID-19 Vaccine.
  • After completion of the primary series, children 6 months and up should receive the Updated Booster (bivalent) at least two months after receiving their last dose, regardless of type (primary series or booster).

For more information, please refer to the following resources:

Help Protect Your Child and Your Family

Getting a COVID-19 vaccination can help protect your child from getting COVID-19. Early information shows that the vaccines may help keep people from spreading COVID-19 to others. They can also help keep your child from getting seriously sick even if they do get COVID-19. Help protect your whole family by getting yourself and your children vaccinated against COVID-19.

COVID-19 vaccines are safe

COVID-19 vaccines are effective

  • COVID 19-vaccines are effective. They can keep you from getting and spreading the virus that causes COVID-19. Learn more about the different COVID-19 vaccines.
  • COVID-19 vaccines also help keep you from getting seriously ill even if you do get COVID-19.
  • Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.

Preparing for Your Child’s Vaccination Visit

  • Tips for how to support your child before, during, and after the visit.
  • Talk to your child before the visit about what to expect
  • Tell the doctor or nurse about any allergies your child may have.
  • Comfort your child during the appointment.
  • After your child’s COVID-19 vaccination, you will be asked to stay for 15–30 minutes so your child can be observed in case they have a severe allergic reaction and need immediate treatment.
  • For more information on preparing for your child’s vaccination, please visit: CDC COVID-19 Vaccines for Children and Teens.

Vaccination of Minors FAQs

The federal government does not have specific requirements for medical consent for vaccination. States/jurisdictions have medical consent laws that address the circumstances under which a medical provider must seek consent prior to a medical procedure and the processes for obtaining that consent. These laws vary across jurisdictions. Providers may also be subject to policy requirements for consent within their own organizations.

To access COVID-19 vaccine in the United States, a provider must enroll in the Centers for Disease Control and Prevention (CDC) COVID-19 Vaccination Program and sign the applicable CDC Provider Agreement. The CDC COVID-19 Vaccination Program Provider Agreement requires the provider to comply with applicable patient assent and consent laws in their state/jurisdiction for administration of COVID-19 vaccines.

If a minor is vaccinated at a County vaccine clinic or special event, a consent form will be required for each child.

NOTE: At any San Bernardino County-operated clinic, a parent or legal guardian is required to both sign the consent and remain present with the minor in order for the child to be vaccinated. 

Some state, tribal, and territorial laws may require a parent or legal guardian to accompany an eligible minor to receive vaccinations. Some jurisdictions’ laws may allow parent/guardian consent without a requirement to be physically present for the vaccination if the provider is given evidence of the consent prior to vaccination. Providers may also have to comply with policy requirements determined by their organization.

At any San Bernardino County operated clinic, a parent or legal guardian is required to both sign the consent and remain present with the minor (aged 17 or younger) in order for the child to be vaccinated.

The Pfizer-BioNTech COVID-19 vaccines for children aged 6 months to 4 years and 5 to 11 years are new products with new packaging, new product configuration, different dosage and injection volumes, and have new National Drug Codes (NDC); however, the formula of the vaccine will remain the same. Current products for adults and adolescents cannot be used in children under 12 years of age.

The Moderna COVID-19 vaccines for children aged 6 months to 4 years are new products with new packaging, new product configuration, different dosage and injection volumes, and have new National Drug Codes (NDC); however, the formula of the vaccine will remain the same. Current products for adults and adolescents cannot be used in children under 11 years of age.

  • The FDA-approved Comirnaty (COVID-19 Vaccine, mRNA) and the FDA-authorized Pfizer-BioNTech COVID-19 Vaccine under Emergency Use Authorization (EUA) have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series.
  • COVID-19 vaccines are authorized for use through a full-approval or an emergency use authorization issued by the U.S Food and Drug Administration (FDA).
  • The COVID-19 vaccine has shown effective at helping to protect against severe disease and death caused by SARS CoV-2.
  • The FDA-approved Spikevax (COVID-19 Vaccine, mRNA) and the FDA-authorized Moderna COVID-19 Vaccine under Emergency Use Authorization (EUA) have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series.
  • COVID-19 vaccines are authorized for use through a full-approval or an emergency use authorization issued by the U.S Food and Drug Administration (FDA).
  • The COVID-19 vaccine has shown effective at helping to protect against severe disease and death caused by SARS CoV-2.

COVID-19 bivalent boosters are vaccines that contain two components: a component of the original virus strain to provide broad protection against COVID-19 and a component of the omicron variant to provide better protection against COVID-19 caused by the omicron variant. Read more at: COVID-19 Bivalent Vaccine Boosters.

Side effects after COVID-19 vaccination vary among age groups. Visit Possible Side Effects to learn more. Reported side effects were mild and similar to those experienced after routine vaccines.
These side effects may affect your child’s ability to do daily activities, but they should go away in a few days. Some children have no side effects. Adverse events, including severe allergic reactions, after COVID-19 vaccination are rare but can happen. For this reason, everyone who receives a COVID-19 vaccine is monitored by their vaccination provider for at least 15 minutes.
The benefits of COVID-19 vaccination outweigh the known and potential risks.

The benefits of COVID-19 vaccination outweigh the known and potential risks.